Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Vicki Poole Hoffmann, PharmD
JCP
Original Research
Pharmacogenomic Associations With Weight Gain in Olanzapine Treatment of Patients Without Schizophrenia
August 15, 2012
John P. Houston
,
Jared Kohler
,
Jeffrey R. Bishop
, et al
JCP
Original Research
Analysis of Gene Variants Previously Associated With Iloperidone Response in Patients With Schizophrenia Who Are Treated With Risperidone
July 12, 2011
Bonnie A. Fijal
,
Virginia L. Stauffer
,
Bruce J. Kinon
, et al
JCP
Original Research
Assessment of Treatment Algorithms Including Amantadine, Metformin, and Zonisamide for the Prevention of Weight Gain With Olanzapine: A Randomized Controlled Open-Label Study
May 17, 2011
Vicki Poole Hoffmann
,
Michael Case
,
Jennie G. Jacobson
JCP
Letter to the Editor
What Do We Know About Insulin Resistance and Glucose Metabolism in Patients With Schizophrenia Treated With Antipsychotics?
May 15, 2007
Jamie Karagianis
,
Vicki Poole Hoffmann
,
Virginia L. Stauffer
, et al
JCP
Original Research
Wellness Intervention for Patients With Serious and Persistent Mental Illness
December 15, 2005
Vicki Poole Hoffmann
,
Jonna Ahl
,
Adam Meyers
, et al
